PPT-An alternative to warfarin for patients with

PE Author Anne Mounsey MD University of North Carolina PURL Journal Club Documents Included Instructions Speaker Notes Including Citation to Original Article Journal Club Worksheet Published PURL. Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. Nothing to disclose. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. (. N. OAC). Dan . Moellentin. , . PharmD. , BCPS, Associate Professor . Husson. University. Strokes in Atrial Fibrillation. 1/5 of strokes are caused by a. fib. 1/3 cardiac arrhythmias hospitalizations . Nicolas Novitzky. The Ideal Oral Anticoagulant. Ideally, an oral anticoagulant would: . Have high . efficacy. in reducing thromboembolic events. Reach . therapeutic levels . within several hours. Oral. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Anticoagulant drugs. Anticoagulant drugs can be divided into two categories: oral and . Meta-Analysis and Implications . David R. Holmes, Jr., M.D.. Mayo Clinic, Rochester . TCT 2014. Washington, D.C.. September 2014. Presenter Disclosure Information. David R. Holmes, Jr., M.D.. “. Watchman II: PROTECT AF/PREVAIL. , MD, PhD . Monday Morning Conference. Oct 4, 2010. Rivaroxaban. Dabigatran. Classes. Unfractionated. heparin. Direct thrombin inhibitors. Low molecular weight heparins, . fondiparinux. Vitamin K antagonists, Inhibiting clotting factors: II, VII, IX, X. Meta-Analysis and Implications . David R. Holmes, Jr., M.D.. Mayo Clinic, Rochester . TCT 2014. Washington, D.C.. September 2014. Presenter Disclosure Information. David R. Holmes, Jr., M.D.. “. Watchman II: PROTECT AF/PREVAIL. Martha Drake MS, FNP-BC. Chicago Heart and Vascular Consultants, LTD. Purdue Northwest Doctorate of Nursing Program. Learning Objectives. Discuss the incidence of atrial fibrillation (AF) in the population. Introduction/Overview . VKA-Associated Bleeding: . Results From the RADOA Registry . Reversal Agents for VKA-Associated Anticoagulation. Management of Urgent Anticoagulation Reversal: . 4F-PCC vs FFP. Why Anticoagulate?. Anticoagulate Even in High-Risk Patients ?. Efficacy and Safety of NOACs vs Warfarin in NVAF by Age. Efficacy and Safety of Edoxaban . vs Warfarin by Age in ENGAGE AF-TIMI 48. Efficacy and Safety of NOACs vs Warfarin in the ≥75 Age Group. Advantages of NOACs. No INR monitoring required. No bridging required . Easier to manage around surgical procedures. Convenient for rural patients or those with other barriers to . clinic . visits. Fewer. hip fractures. Dr Linda Xu . linda.xu@health.nsw.gov.au. Dr Nichola Boyle . Prof LeCouteur. Concord Repatriation General Hospital, NSW Australia. Background. Hip fracture most costly fracture type based on “per fracture” basis. Oliguria. Hypoxia. Tachycardia. Cover Shifts part 3 - Dr Carol Chong. What meds are in your armamentarium?. Constipation. 1/7 of constipation. Coloxyl. and . senna. 2 tablets . b.d. +. Lactulose. 20mls o . NOAC vs Warfarin Atrial Fibrillation Studies – Asian representation. RE-LY. ROCKET. ARISTOTLE. ENGAGE. Drug. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. Class. DTI. Anti-. Xa. Anti-. Xa. Anti-. Xa.